CTNNBL1 and hypertriglyceridemia: In contrast, the long-term D-Nap-GFFY-T317 injection had no effect on either lipid profiles or activity of aminotransferase (Table 3), suggesting the long-term D-Nap-GFFY-T317 treatment can block T317-induced hypertriglyceridemia and fatty liver.